0
Enliven Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.4
FY22:
−38.8
FY23:
−83.5
FY24:
−105
FY25:
−120
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−38.6
FY23:
−83.2
FY24:
−105
FY25:
−119
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.4
FY22:
1.58
FY23:
−71.6
FY24:
−88.8
FY25:
−104
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.4
FY22:
−37.7
FY23:
−71.6
FY24:
−89.0
FY25:
−104
All amounts in millions USD